Skip to main content

Table 1 Baseline patient characteristics according to presence or absence of late gadolinium enhancement on cardiac MRI

From: Myocardial characterization in pre-dialysis chronic kidney disease: a study of prevalence, patterns and outcomes

 LGEposn= 55LGEnegn= 104Pvalue
Age (years)57 ± 1253 ± 130.069
Male sex n (%)38 (69)59 (57)0.171
BMI28 ± 427 ± 40.088
eGFR (ml/min/1.73m2)54 ± 1552 ± 160.502
KDIGO stage n (%)  0.649
 2 (eGFR 60–89 ml/min/1.73m2)22 (40)32 (31) 
 3a (eGFR 45–59 ml/min/1.73m2)17 (30)35 (33) 
 3b (eGFR 30–44 ml/min/1.73m2)14 (26)29 (28) 
 4 (eGFR 15–29 ml/min/1.73m2)2 (4)8 (8) 
Aetiology n (%)  0.117
 Vasculitis7 (13)9 (9) 
 GN15 (27)49 (47) 
 Hereditary10 (18)13 (12) 
 Systemic8 (14)9 (8) 
 Infective2 (4)4 (4) 
 Obstruction4 (7)3 (3) 
 Hypertensive1 (2)5 (5) 
 Interstitial0 (0)6 (6) 
 Vascular1 (2)1 (1) 
 Unknown7 (13)5 (5) 
Systolic BP (mmHg)128 ± 17126 ± 140.431
Diastolic BP (mmHg)78 ± 1177 ± 100.710
Haemoglobin (g/L)138 ± 14132 ± 220.057
Total cholesterol (mg/dL)90 ± 1890 ± 180.575
NTproBNP (pg/mL)55 [34–93]59 [17–161]0.656
Immunosuppression usage n (%)16 (29)22 (21)0.326
Anti-hypertensive usage n (%)45 (82)83 (80)0.822
Statin usage n (%)24 (46)39 (37)0.388
ECG n (%)
 Q waves3 (5)4 (4)0.931
 T inversion5 (9)12 (11)0.789
  1. Continuous variables are presented as mean ± SD if normally distributed or medians and [25th–75th percentile] for skewed variables. Categorical variables are presented as n (valid %). Significant p values are bold
  2. BMI Body mass index, BP blood pressure, eGFR estimated glomerular filtration rate. GN Glomerulonephritis. KDIGO Kidney Disease Improving Global Outcomes. LGEpos Patients with late gadolinium enhancement. LGEneg Patients without late gadolinium enhancement